Compile Data Set for Download or QSAR
Report error Found 73 Enz. Inhib. hit(s) with all data for entry = 7405
TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193022(US9193726, 10)
Affinity DataIC50: 3.34nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193067(US9193726, 55)
Affinity DataIC50: 5.48nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193079(US9193726, 67)
Affinity DataIC50: 5.78nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193081(US9193726, 69)
Affinity DataIC50: 7.84nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193063(US9193726, 51)
Affinity DataIC50: 8.35nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193021(US9193726, 9)
Affinity DataIC50: 9.10nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193082(US9193726, 70)
Affinity DataIC50: 10nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193062(US9193726, 50)
Affinity DataIC50: 11nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193069(US9193726, 57)
Affinity DataIC50: 11.1nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193066(US9193726, 54)
Affinity DataIC50: 11.4nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193074(US9193726, 62)
Affinity DataIC50: 13.3nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193020(US9193726, 8)
Affinity DataIC50: 14.3nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193070(US9193726, 58)
Affinity DataIC50: 14.5nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193064(US9193726, 52)
Affinity DataIC50: 15nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193059(US9193726, 47)
Affinity DataIC50: 15.7nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193030(US9193726, 18)
Affinity DataIC50: 16nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193085(US9193726, 73)
Affinity DataIC50: 19.8nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193061(US9193726, 49)
Affinity DataIC50: 21.6nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193080(US9193726, 68)
Affinity DataIC50: 24.2nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193073(US9193726, 61)
Affinity DataIC50: 24.6nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193018(US9193726, 6)
Affinity DataIC50: 25nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193057(US9193726, 45)
Affinity DataIC50: 26.6nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193077(US9193726, 65)
Affinity DataIC50: 26.8nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193055(US9193726, 43)
Affinity DataIC50: 27.6nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193065(US9193726, 53)
Affinity DataIC50: 29.1nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193027(US9193726, 15)
Affinity DataIC50: 29.9nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193078(US9193726, 66)
Affinity DataIC50: 33.5nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193029(US9193726, 17)
Affinity DataIC50: 38.4nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193023(US9193726, 11)
Affinity DataIC50: 40.5nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193084(US9193726, 72)
Affinity DataIC50: 46.4nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193056(US9193726, 44)
Affinity DataIC50: 52.1nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193083(US9193726, 71)
Affinity DataIC50: 52.4nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193058(US9193726, 46)
Affinity DataIC50: 60.3nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193015(US9193726, 3)
Affinity DataIC50: 60.6nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193060(US9193726, 48)
Affinity DataIC50: 63.8nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193075(US9193726, 63)
Affinity DataIC50: 73.3nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193072(US9193726, 60)
Affinity DataIC50: 73.3nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193019(US9193726, 7)
Affinity DataIC50: 73.5nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193076(US9193726, 64)
Affinity DataIC50: 73.5nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193041(US9193726, 29)
Affinity DataIC50: 80nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193068(US9193726, 56)
Affinity DataIC50: 81.2nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193028(US9193726, 16)
Affinity DataIC50: 96.6nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193035(US9193726, 23)
Affinity DataIC50: 98nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193051(US9193726, 39)
Affinity DataIC50: 112nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193054(US9193726, 42)
Affinity DataIC50: 117nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193046(US9193726, 34)
Affinity DataIC50: 120nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193017(US9193726, 5)
Affinity DataIC50: 140nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193048(US9193726, 36)
Affinity DataIC50: 146nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193052(US9193726, 40)
Affinity DataIC50: 153nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

TargetPresenilin-1(Human)
Pfizer

US Patent
LigandPNGBDBM193053(US9193726, 41)
Affinity DataIC50: 157nMT: 2°CAssay Description:The ability of compounds to modulate production of amyloid beta protein Abeta(1-42) was determined using human WT-APP overexpressing CHO cells. Cells...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2016
Entry Details
Go to US Patent

Displayed 1 to 50 (of 73 total ) | Next | Last >>
Jump to: